PROTEIN DESIGN LAB LTD has a total of 82 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PERSONGEN BIOMEDICINE SUZHOU CO LTD, ADICET BIO INC and SANGAMO THERAPEUTICS FRANCE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Republic of Korea | 5 | |
#5 | Singapore | 5 | |
#6 | Taiwan | 5 | |
#7 | South Africa | 5 | |
#8 | African Regional Industrial Property Organization | 4 | |
#9 | Brazil | 4 | |
#10 | Canada | 4 | |
#11 | Israel | 4 | |
#12 | New Zealand | 4 | |
#13 | EAPO (Eurasian Patent Organization) | 3 | |
#14 | Colombia | 2 | |
#15 | India | 2 | |
#16 | Peru | 2 | |
#17 | Philippines | 2 | |
#18 | United States | 2 | |
#19 | Chile | 1 | |
#20 | Costa Rica | 1 | |
#21 | Cuba | 1 | |
#22 | Dominican Republic | 1 | |
#23 | Georgia | 1 | |
#24 | Hong Kong | 1 | |
#25 | Hungary | 1 | |
#26 | Japan | 1 | |
#27 | Morocco | 1 | |
#28 | Mexico | 1 | |
#29 | Malaysia | 1 | |
#30 | Tunisia | 1 | |
#31 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Chemical or physical processes | |
#6 | Analysing materials | |
#7 | Fermentation | |
#8 | Water treatment |
# | Name | Total Patents |
---|---|---|
#1 | Qiu Xiaoqing | 69 |
#2 | Xiaoqing Qiu | 8 |
#3 | Qiu Xiao-Qing | 4 |
Publication | Filing date | Title |
---|---|---|
TW201934576A | Drug used for preventing Mycobacterium tuberculosis and Mycobacterium tuberculosis infection, and applications thereof having recombinant polypeptide structure | |
WO2018121499A1 | Drug resistant to mycobacterium tuberculosis and to infection with mycobacterium tuberculosis, and application of drug | |
NZ627116A | Novel antibiotic preparation method and platform system based on same | |
TW201422816A | A Method for Highly Efficient Expression of Recombinant Protein from Engineering Bacteria and Its Application | |
EA025689B1 | Method for highly expressing recombinant protein of engineering bacteria and use thereof | |
TW201408776A | Anti-cyanobacteria recombinant antibody polypeptide and its gene and preparation method | |
KR20140145951A | Anti-cyanobacteria recombinant antibody polypetide, gene thereof preparation method thereof | |
TW201229237A | A novel anti-EB virus-induced tumor polypeptide, a gene encoding it and a plastid containing the gene, and its application and its preparation method | |
NZ598593A | A new antibiotic containing simulacrum antibody, preparation methods and application thereof | |
AP201206327A0 | Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |